ALISSA LEDGERWOOD: Open Payments
NPI 1770971343 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,094 in 162 payments from 20 companies in 2025. Trend: 2023 $2,941 · 2024 $2,772 · 2025 $3,094
Food & beverage: $3,094
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $404 |
| ABBVIE INC. | 18 | $355 |
| PFIZER INC. | 33 | $323 |
| UCB, Inc. | 15 | $307 |
| Novartis Pharmaceuticals Corporation | 18 | $299 |
| Janssen Biotech, Inc. | 11 | $237 |
| AstraZeneca Pharmaceuticals LP | 7 | $222 |
| GENZYME CORPORATION | 7 | $207 |
| Ferring Pharmaceuticals Inc. | 5 | $130 |
| Mallinckrodt Hospital Products Inc. | 4 | $124 |
Products named: XELJANZ, Bimzelx, COSENTYX, TREMFYA, RINVOQ, KEVZARA, SAPHNELO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
